Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,726 public trials 1,768 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, Not Recruiting

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

NCT04915755

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • GSK Investigational Site Burbank, California, United States
  • GSK Investigational Site Duarte, California, United States
  • GSK Investigational Site Palo Alto, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 198 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

NCT03725059

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Southern Cancer Center, PC ( Site 8003) Daphne, Alabama, United States
  • Cancer Treatment Centers of America at Western Regional Medical Center ( Site 0001) Goodyear, Arizona, United States
  • Arizona Oncology Associates PC- HOPE ( Site 8008) Tucson, Arizona, United States
  • Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0079) Los Angeles, California, United States
View all 244 locations
View Trial Details
Active, Not Recruiting

Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer

NCT02455141

Conditions
Breast Diseases, Breast Neoplasm, Breast Neoplasms, +4 more
Locations
  • Fuding Hospital Fuding, Fujian, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • Quanzhou First Hospital Quanzhou, Fujian, China
  • Foshan No.1 People's Hospital Foshan, Guangdong, China
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

NCT02755272

Conditions
Breast Diseases, Breast Neoplasms, Carcinoma Breast Stage IV, +5 more
Locations
  • Indiana University Indianapolis, Indiana, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • Duke University Durham, North Carolina, United States
View Trial Details

Related conditions